Journal of Cancer Therapy
Vol.6 No.10(2015), Paper ID 59397, 8
pages
DOI:10.4236/jct.2015.610091
Healthcare Resource Utilization and Associated Costs in Patients with Advanced Melanoma Receiving First-Line Ipilimumab
Ahmad Tarhini, Shelby L. Corman, Sumati Rao, Kim Margolin, Xiang Ji, Sonam Mehta, Marc F. Botteman
University of Pittsburgh Cancer Institute, Pittsburgh, USA
Pharmerit International, Bethesda, USA
Bristol-Myers Squibb, Plainsboro, USA
Stanford University, Stanford, USA
Pharmerit International, Bethesda, USA
Pharmerit International, Bethesda, USA
Pharmerit International, Bethesda, USA
Copyright © 2015 Ahmad Tarhini, Shelby L. Corman, Sumati Rao, Kim Margolin, Xiang Ji, Sonam Mehta, Marc F. Botteman et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Tarhini, A. , Corman, S. , Rao, S. , Margolin, K. , Ji, X. , Mehta, S. and Botteman, M. (2015) Healthcare Resource Utilization and Associated Costs in Patients with Advanced Melanoma Receiving First-Line Ipilimumab.
Journal of Cancer Therapy,
6, 833-840. doi:
10.4236/jct.2015.610091.